Biosynthesis of prostaglandin E 2 (PGE 2 ), the most common prostanoid with potent and various biological activities, is regulated by three sequential steps of cyclooxygenase (COX) pathway. We reported the molecular identification of cytosolic prostaglandin E synthase (cPGES), a terminal enzyme of the COX-mediated PGE 2 biosynthetic pathway. Of interest, it is identical to the co-chaperone p23 that binds to heat shock protein 90 (Hsp90). Incubation of recombinant cPGES/p23 and Hsp90 resulted in a remarkable increase in PGES activity in vitro. Furthermore, A23187-induced PGE 2 generation in 3Y1 cells was suppressed by Hsp90 inhibitors, which destabilized the cPGES/p23-Hsp90 complex, and reduced cPGES/p23 activity and PGE 2 production to basal levels. Next, we found that cPGES/p23 underwent serine phosphorylation, which was accelerated transiently after cell activation. In activated cells, cPGES/p23 phosphorylation occurred in parallel with increased cPGES/p23 enzymic activity and PGE 2 production from exogenous and endogenous arachidonic acid, and these processes were facilitated by Hsp90 that formed a tertiary complex with cPGES/p23 and protein kinase CK2. Treatment of cells with inhibitors of CK2 and Hsp90 and with a dominant-negative CK2 attenuated the formation of the cPGES/p23-CK2-Hsp90 complex and attendant cPGES/p23 phosphorylation and activation. Mutations of either of two predicted CK2 phosphorylation sites on cPGES/p23 (Ser 113 and Ser 118 ) abrogated its phosphorylation and activation both in vitro and in vivo. These results provide the first evidence that the cellular function of this eicosanoid-biosynthetic enzyme is under the control of a molecular chaperone and its client protein kinase.
INTRODUCTION
Prostaglandin E 2 (PGE 2 ) is the most common prostanoid, being produced by a variety of tissues and cells, and has a broad range of biological activity. Three kinds of enzymes, phospholipase A 2 (PLA 2 ), cyclooxygenase (COX), and terminal PGE synthase (PGES) are involved in biosynthesis of PGE 2 and each of the three enzymatic steps involves multiple enzymes and isozymes that can act in different phases of cell activation. [1] [2] [3] [4] [5] Arachidonic acid released from membrane phospholipids by cytosolic PLA 2 α (cPLA 2 α) is then supplied to either of the two COX isozymes, COX-1 or COX-2. COX-1, a constitutive COX isozyme, contributes mainly to immediate PG generation, whereas COX-2, an inducible enzyme, mediates delayed PG generation. The COX metabolite PGH 2 is then isomerized to PGE 2 by the terminal PGES enzymes.
Cytosolic PGES (cPGES) is a 23 kDa glutathione (GSH)-requiring enzyme expressed constitutively in a wide variety of cells. 6) This enzyme is selectively coupled with COX-1 to mediate immediate PGE 2 production. Of particular note, cPGES is identical to the co-chaperone p23, which is associated with heat shock protein 90 (Hsp90). 7) In contrast, the GSH-dependent, membrane-bound PGES (mPGES)-1 is markedly induced by proinflammatory stimuli, down-regulated by glucocorticoids, and functionally coupled with COX-2. 8, 9) mPGES-2 has a glutaredoxin-or thioredoxin-like domain and is activated by several thiol reagents. 10) This enzyme is constitutively expressed in various cells and can be coupled with both COX-1 and COX-2. 11) Here, we briefly review our recent studies on the regulatory mechanism of cPGES/p23 in rat fibroblastic 3Y1 cells. Association of cPGES/p23 with Hsp90 was increased in cells stimulated with Ca 2+ mobilizer, accompanied by concomitant increases in cPGES/p23 enzymic activity and PGE 2 production. 12) cPGES/p23 also underwent phosphorylation by protein kinase CK2, leading to increase in cPGES/p23 enzymic activity and association of cPGES/p23 with Hsp90. 13) Taken together, our results suggest that the cellular PGE 2 -biosynthetic function is under the control of a molecular chaperone and its client protein kinase.
REGULATION BY Hsp90
Incubation of bacterial expression systemderived recombinant cPGES/p23 with Hsp90 in vitro in the presence of ATP and Mg 2+ resulted in not only the formation of cPGES/p23-Hsp90 complex, but also a remarkable increase in cPGES activity (Fig. 1 ). This result is consistent with the fact that both ATP and Mg 2+ are necessary for the formation of the cPGES/p23-Hsp90 complex. 14) Next, we examined interaction between cPGES/p23 and Hsp90 in rat fibroblastic 3Y1 cells, in which cPGES/p23 is the predominant PGES enzyme. Stimulation of 3Y1 cells with Ca 2+ -ionophore A23187 elicited immediate PGE 2 syn- thesis. The increase of PGE 2 synthesis was preceded by that of cPGES/p23 enzymic activity in cell lysates, which occurred within 1 min and peaked at 15 min. Immunoprecipitation of the cell lysates with anti-cPGES/p23 antibody revealed that more Hsp90 was co-precipitated with cPGES/p23 from A23187-treated cells than from untreated cells, indicating that there was an increased association between cPGES/p23 and Hsp90 following cell activation. To assess whether cPGES/p23 activation occurs even by physiological stimulus, 3Y1 cells were treated with bradykinin. Stimulation of cells with bradykinin resulted in increased PGE 2 synthesis and PGES activity in cell lysates, which were accompanied by increased association between cPGES/p23 and Hsp90.
Treatment of the cells with the Hsp90 inhibitors, geldanamycin and novobiocin, each of which binds to the ATP-binding site on Hsp90 and inhibits its chaperone function, 15, 16) reduced this stimulus-increased association between cPGES/p23 and Hsp90 to a basal level.
The dissociation of the cPGES/p23-Hsp90 complex by the Hsp90 inhibitors was accompanied by suppression of bradykinin-induced PGE 2 synthesis and cPGES/p23 activation.
Thus, it appears that stimulus-induced formation of the cPGES/p23-Hsp90 complex is correlated with the activity of cPGES/p23 to synthesize PGE 2 in cells.
REGULATION BY PHOSPHORYLATION
There are several potential phosphorylation sites in the primary amino acid sequence of human cPGES/p23 17, 18) [ Fig. 2(A) ]. To clarify whether or not cPGES/p23 undergoes phosphorylation in cells, 3Y1 cells were pre-cultured with [ 32 P]orthophosphate, and cPGES/p23 protein was immunoprecipitated from the cell lysates of these cells, resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and subjected to autoradiography. There was a significant incorporation of radioactivity into cPGES/p23 protein even under basal culture conditions, and this phosphorylation was significantly increased in cells stimulated for 1 min with A23187. Phospho-amino acid analysis revealed that this phosphorylation occurred predominantly on serine, but not threonine or tyrosine, residues with or without A23187 treatment. Protein phosphatase treatment of cell lysate decreased cPGES/p23 activity by >90%, suggesting that phosphorylation of cPGES/p23 is crucial for its enzymic function. Judging from the effects of several protein kinase inhibitors on conversion of exogenous arachidonic acid to PGE 2 in 3Y1 cells, protein kinase CK2 may be involved in phosphorylation and activation of cPGES/p23, and protein kinase C (PKC) and Ca 2+ /calmodulin kinase II (CaMKII) are not. To confirm this possibility, we examined using an in vitro kinase assay under conditions where recombinant cPGES/p23 was incubated with recombinant CK2 in the presence of Mg 2+ and [ 32 P]ATP. A marked incorporation of 32 P into cPGES/p23 protein was observed, indicating that cPGES/p23 is directly phosphorylated by CK2 in vitro [ Fig. 2(B) ]. Furthermore, the enzymatic activity of cPGES/p23 was significantly increased following incubation with CK2. When Hsp90 was added to this in vitro kinase assay mixture, there were further increases in 32 P incorporation into cPGES/p23 protein and in cPGES/p23 enzymatic activity [ Fig. 2(B) ]. To clarify whether cPGES/p23 directly associates with CK2 or not, a mixture of the two was immunoprecipitated with anti-cPGES/p23 antibody and then immunoblotted with anti-CK2 antibody. CK2 was co-precipitated with cPGES/p23, and vice versa. Hsp90 was added to this mixture, it was co-precipitated with cPGES/p23 and CK2 by anticPGES/p23 antibody, and more CK2 was associated with cPGES/p23. These results suggest that the formation of the ternary complex containing cPGES/p23, CK2 and Hsp90 facilitates phosphorylation of cPGES/p23 by CK2.
Next, we examined whether the formation of cPGES/p23-CK2-Hsp90 complex with its at-tendant phosphorylation is crucial for the PGE 2 -biosynthetic function of cPGES/p23 in vivo. Stimulation of 3Y1 cells with bradykinin resulted in immediate PGE 2 synthesis, which increased linearly during the initial 3 min and then reached a plateau, correlating with transient phosphorylation of cPGES/p23 which peaked at 1 min and then decreased to the basal level by 5-10 min [ Fig. 3(A) ]. In parallel with cPGES/p23 phosphorylation, cPGES/p23 enzymic activity in cell lysates was increased markedly at 1 min and declined at 10 min [ Fig. 3(B), lower panel] . Association of cPGES/p23 with CK2 was also markedly elevated at 1 min and then returned to the basal level. Furthermore, association of cPGES/p23 with Hsp90 was transient, peaking at 1 min and returning to the basal level by 10 min [ Fig. 3(B) , upper panel]. Moreover, the CK2 inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) or the Hsp90 inhibitor geldanamycin markedly inhibited bradykinin-induced PGE 2 synthesis, cPGES/p23 activation, and association of cPGES/p23 with CK2 and Hsp90 [ Fig. 3(C), (D) ]. These results suggest that Hsp90 acts as scaffold protein that brings cPGES/p23 and CK2 in proximity, thereby allowing their efficient functional interaction under physiological conditions. To verify the contribution of CK2 to cPGES/p23 activation, we took advantage of DN-CK2, which harbors a mutation (D156A) in the kinase domain and thereby blocks the cellular functions of CK2. 19) Overexpression of DN-CK2 in 3Y1 cells resulted in decrease of phosphorylation of cPGES/p23 and association of cPGES/p23 with Hsp90 relative to those in mock-transfected cells. Accordingly, cPGES/p23 enzymic activity in the lysates of DN-CK2-transfected cells was approximately half that of mock-transfected cells. Moreover, PGE 2 synthesis by DN-CK2-transfected cells from exogenous arachidonic acid or in response to A23187 was also reduced by half as compared with that of mock-transfectant. These results indicate that complex formation of cPGES/p23 with CK2 and Hsp90, and concomitant phosphorylation by CK2 are essential for the activation of cPGES/p23 in cells.
To address which residues of cPGES/p23 are phosphorylated by CK2 in cells, we constructed point mutants of cPGES/p23 in which each CK2-consensus Ser residue was replaced with Ala or Gly (S113A, S118A and S151G). These mutants and wild type (WT) of cPGES/p23 were transfected into 3Y1 cells, and their enzymic activities and PGE 2 synthesis were determined. cPGES/p23 enzymic activity was increased significantly in cells transfected with WT or S151G, whereas the activity in cells transfected with S113A or S118A was comparable with that in parental cells [ Fig. 4(A) ]. PGE 2 synthesis induced by bradykinin was markedly elevated when WT or S151G was transfected, whereas in the case of S113A or S118A it was not significantly altered [ Fig. 4(B) ]. Immunoprecipitation analysis of 32 P-pre-labeled cells revealed that phosphorylation of cPGES/p23 occurred in WT-or S151G-transfected cells, and not in S113A or S118A-transfected cells [ Fig. 4(C) ]. Judging from these results, we conclude that Ser 113 and Ser 118 are the predominant CK2 phosphorylation sites critical for cPGES/p23 activation in cells, and that phosphorylation of these two Ser residues promotes associ- proteins. Cells pre-labeled with 32 P were lysed and were subjected to immunoprecipitation (IP) with anti-FLAG antibody. Individual samples were resolved by SDS-PAGE and were subjected to autoradiography or immunoblotting with anti-FLAG antibody.
ation of cPGES/p23 with Hsp90.
In summary, we propose that functional cPGES/p23 exists in cells as a multicomponent complex containing CK2 and Hsp90 as the minimal requirements. CK2 activated by upstream signals triggers dual phosphorylation of Ser 113 and Ser 118 on cPGES/p23, which in turn facilitates the recruitment of cPGES/p23 to the Hsp90 complex, leading to its full activation. In porcine endothelial cells, bradykinin induces phosphorylation of angiotensin-converting enzyme by CK2, 20) consistent with our findings that bradykinin elicits CK2-dependent cPGES/p23 activation, although the signaling from bradykinin to CK2 activation remains to be elucidated. Our results have provided the first evidence that the function of PGES is elegantly controlled by a particular protein kinase in cooperation with a molecular chaperone.
